PHARMACOLOGY OF LOW MOLECULAR WEIGHT HARPARINS
- 1 November 2001
- journal article
- Published by Elsevier in Emergency Medicine Clinics of North America
- Vol. 19 (4) , 1025-1049
- https://doi.org/10.1016/s0733-8627(05)70233-9
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Published by Elsevier ,2000
- Interaction between the LMWH reviparin and aspirin in healthy volunteersPublished by Wiley ,2000
- Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: Tolerance of a new recombinant hirudinJournal of the American Academy of Dermatology, 2000
- Adverse Skin Reactions to Low Molecular Weight HeparinsDrug Safety, 1999
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding studyThe Journal of Pediatrics, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995